| scholarly article | Q13442814 |
| P50 | author | Cynthia V Calkin | Q60622547 |
| Claire O'Donovan | Q37391998 | ||
| Julie Garnham | Q41118805 | ||
| Tomas Hajek | Q47822374 | ||
| P2093 | author name string | Martin Alda | |
| Claire Slaney | |||
| Caroline van de Velde | |||
| Martina Růzicková | |||
| P2860 | cites work | Suicide attempts and ideation in patients with bipolar I disorder. | Q51941123 |
| Abnormalities of the hypothalamic-pituitary-adrenal axis in nondepressed women with abdominal obesity and relations with insulin resistance: evidence for a central and a peripheral alteration | Q57009113 | ||
| Correlates of overweight and obesity in 644 patients with bipolar disorder | Q60646356 | ||
| Increased intra-abdominal fat deposition in patients with major depressive illness as measured by computed tomography | Q60727657 | ||
| Prevalence of overweight and obesity in bipolar patients | Q73805994 | ||
| The association of a HOPA polymorphism with major depression and phobia | Q74745109 | ||
| Psychosocial Disability in the Course of Bipolar I and II Disorders | Q22253033 | ||
| Serotonergic dysregulation in bipolar disorders: a literature review of serotonergic challenge studies | Q31125310 | ||
| Brain dopamine and obesity | Q32040881 | ||
| Psychotropic drugs induced weight gain: a review of the literature concerning epidemiological data, mechanisms and management | Q33230717 | ||
| Excess mortality in bipolar and unipolar disorder in Sweden | Q33954560 | ||
| Obesity and cortisol | Q34071860 | ||
| Serotonin and bipolar disorder | Q34353341 | ||
| Congruencies in increased mortality rates, years of potential life lost, and causes of death among public mental health clients in eight states | Q35024510 | ||
| Bipolar disorder, obesity, and pharmacotherapy-associated weight gain. | Q35631515 | ||
| Obesity in patients with bipolar disorder: a biopsychosocial-behavioral model | Q36539425 | ||
| Medical risk in patients with bipolar disorder and schizophrenia. | Q36590638 | ||
| Genetic variants of the human obesity (OB) gene: association with body mass index in young women, psychiatric symptoms, and interaction with the dopamine D2 receptor (DRD2) gene | Q38353236 | ||
| Common biological pathways in eating disorders and obesity | Q41199350 | ||
| Prospective studies on a lithium cohort. 3. Tremor, weight gain, diarrhea, psychological complaints | Q42211229 | ||
| Weight gain during treatment of bipolar I patients with olanzapine. | Q42644649 | ||
| Prevalence of obesity and weight change during treatment in patients with bipolar I disorder | Q43642752 | ||
| Hypercortisolemic depression is associated with increased intra-abdominal fat. | Q43933213 | ||
| Obesity as a correlate of outcome in patients with bipolar I disorder | Q44265285 | ||
| Hypothalamic-pituitary-adrenal axis function in patients with bipolar disorder | Q44917858 | ||
| Decreased levels of dopamine D3 receptor mRNA in schizophrenic and bipolar patients | Q45148113 | ||
| The long-term natural history of the weekly symptomatic status of bipolar I disorder | Q46317822 | ||
| Metabolic syndrome in bipolar disorder: findings from the Bipolar Disorder Center for Pennsylvanians | Q46714706 | ||
| A genome wide linkage study of obesity as secondary effect of antipsychotics in multigenerational families of eastern Quebec affected by psychoses | Q47272170 | ||
| Impact of lamotrigine and lithium on weight in obese and nonobese patients with bipolar I disorder | Q47331378 | ||
| Early predictors of substantial weight gain in bipolar patients treated with olanzapine | Q47337289 | ||
| Clinical features of bipolar disorder with and without comorbid diabetes mellitus | Q47629610 | ||
| Reduced brain 5-HT and elevated NE turnover and metabolites in bipolar affective disorder | Q48189796 | ||
| P433 | issue | 6 | |
| P921 | main subject | bipolar disorder | Q131755 |
| P304 | page(s) | 650-656 | |
| P577 | publication date | 2009-09-01 | |
| P1433 | published in | Bipolar Disorders | Q15716681 |
| P1476 | title | Can body mass index help predict outcome in patients with bipolar disorder? | |
| P478 | volume | 11 |
| Q42751743 | A brief motivational intervention for preventing medication-associated weight gain among youth with bipolar disorder: treatment development and case report |
| Q89450173 | A comparison study of metabolic profiles, immunity, and brain gray matter volumes between patients with bipolar disorder and depressive disorder |
| Q92892412 | A systematic review and meta-analysis of clinical predictors of lithium response in bipolar disorder |
| Q40842714 | Abdominal obesity is associated with impaired cognitive function in euthymic bipolar individuals |
| Q52565175 | An immunological age index in bipolar disorder: A confirmatory factor analysis of putative immunosenescence markers and associations with clinical characteristics. |
| Q38378743 | Are medical comorbid conditions of bipolar disorder due to immune dysfunction? |
| Q47859658 | Association of body mass index-related single nucleotide polymorphisms with psychiatric disease and memory performance in a Japanese population |
| Q90589658 | Association of polygenic score for major depression with response to lithium in patients with bipolar disorder |
| Q38023889 | Beyond the guidelines for bipolar disorder: practical issues in long-term treatment with lithium. |
| Q47667767 | Bipolar Disorder and Immune Dysfunction: Epidemiological Findings, Proposed Pathophysiology and Clinical Implications |
| Q57533247 | Bipolar disorder and adiposity: a study using whole body dual energy X-ray absorptiometry scans |
| Q45236327 | Bipolar disorder symptoms in patients seeking bariatric surgery |
| Q51313037 | Body fat distribution and associations with metabolic and clinical characteristics in bipolar individuals. |
| Q47913705 | Body mass index associates with white matter microstructure in bipolar depression. |
| Q44142664 | Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013. |
| Q33795131 | Cardiometabolic Health in Bipolar Disorder |
| Q38781602 | Childhood trauma and mixed episodes are associated with poor response to lithium in bipolar disorders |
| Q41337124 | Clinical phenotype of bipolar disorder with comorbid binge eating disorder. |
| Q35848001 | DNA methylation, insulin resistance and second-generation antipsychotics in bipolar disorder. |
| Q91386045 | Evidence that genes involved in hedgehog signaling are associated with both bipolar disorder and high BMI |
| Q90428150 | Impact of metabolic syndrome and clinical features on functioning in patients with bipolar disorder: a cross-sectional study |
| Q92058586 | Improving Functioning, Quality of Life, and Well-being in Patients With Bipolar Disorder |
| Q37896630 | Insulin dysfunction and allostatic load in bipolar disorder |
| Q50571436 | Insulin resistance in bipolar disorder: relevance to routine clinical care. |
| Q36553562 | Lifestyle interventions targeting dietary habits and exercise in bipolar disorder: A systematic review. |
| Q38799039 | Long-term lithium treatment in bipolar disorder: effects on glomerular filtration rate and other metabolic parameters |
| Q47249575 | Lower cognitive functioning as a predictor of weight gain in bipolar disorder: a 12-month study. |
| Q40294491 | Medical burden, body mass index and the outcome of psychosocial interventions for bipolar depression |
| Q34034971 | Medical comorbidity in bipolar disorder: relationship between illnesses of the endocrine/metabolic system and treatment outcome |
| Q40317424 | Metabolic Syndrome and Bipolar Affective Disorder: A Review of the Literature |
| Q64085328 | Metabolic profile in patients with newly diagnosed bipolar disorder and their unaffected first-degree relatives |
| Q36225626 | Metabolic syndrome and adverse clinical outcomes in patients with bipolar disorder |
| Q34047592 | Metabolic syndrome and childhood trauma: Also comorbidity and complication in mood disorder |
| Q50175494 | Metabolic/inflammatory/vascular comorbidity in psychiatric disorders; soluble epoxide hydrolase (sEH) as a possible new target. |
| Q57454956 | Neurococognitive and neuroimaging correlates of obesity and components of metabolic syndrome in bipolar disorder: a systematic review |
| Q38160202 | Obesity and bipolar disorder: synergistic neurotoxic effects? |
| Q36751327 | Obesity and the three-year longitudinal course of bipolar disorder |
| Q36834290 | Obesity, but not metabolic syndrome, negatively affects outcome in bipolar disorder |
| Q42509069 | Plasma copeptin and metabolic dysfunction in individuals with bipolar disorder |
| Q55002697 | Prediction of response to drug therapy in psychiatric disorders. |
| Q94544871 | Prevalence of Prediabetes and Diabetes Mellitus Type II in Bipolar Disorder |
| Q40361612 | Sex differences in the risk of rapid cycling and other indicators of adverse illness course in patients with bipolar I and II disorder |
| Q37863532 | Surgical treatment of morbid obesity among patients with bipolar disorder: a research agenda |
| Q40554693 | Surrogate markers of visceral fat and response to anti-depressive treatment in patients with major depressive disorder: a prospective exploratory analysis |
| Q35167517 | The burden of obesity among adults with bipolar disorder in the United States |
| Q37351069 | The effect of bariatric surgery on psychiatric course among patients with bipolar disorder |
| Q39100917 | The genetic overlap between mood disorders and cardiometabolic diseases: a systematic review of genome wide and candidate gene studies |
| Q38012489 | The relationship between bipolar disorder and type 2 diabetes: more than just co-morbid disorders |
Search more.